A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric ...

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

Kennedy’s controversial panel overhaul met its first test. The result? A major win for public health ahead of RSV season.

Recent studies have shown convincingly that vaccines against shingles (Herpes zoster) reduce the risk of dementia.

Protection against RSV derived from preF IgG antibodies waned 6 months after infection in an analysis of patients with confirmed disease and household contacts.

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...

CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization ...

RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...